World class sarcoma care in the West Midlands

Meet the Team

The Birmingham Sarcoma Service has a large multidisciplinary team of clinicians, specialist nurses and allied healthcare professionals caring for patients across the three sites – ROH, UHB and BWC.  See below for details of the team.

Royal Orthopaedic Hospital



Professor Abudu

Mr Abudu is a Consultant Orthopaedic Surgeon at the Royal Orthopaedic Hospital NHS Trust.  He qualified as a medical doctor in 1987 with distinction, became a Fellow of the Royal College of Surgeons and Physicians of Glasgow in 1992, gained a Masters degree in Clinical Research in 1997, the Intercollegiate Fellowship in Orthopaedic and Trauma Surgery in 2000 and underwent a fellowship programme in Orthopaedic and Reconstructive Surgery at the University Of Toronto Canada in 2000 to 2001.

Mr Abudu specialises in routine and complex knee surgery. He has particular interests in primary and revision replacements, arthroscopy of knee joints, correction of major bone deformities, bone and joint infections, treatment of failed knee replacements, bone and soft tissue lumps, and major bone defects. Mr Abudu has been an invited surgeon and lecturer in many countries outside the United Kingdom including the USA, Canada, Spain, Italy, Belgium, Holland, Denmark, Australia, Portugal, Germany, Norway, Austria, Brazil, India, and Malaysia among others.

Professor Jeys

Professor Jeys is a Consultant Orthopaedic Surgeon at the Royal Orthopaedic Hospital NHS Trust. He performs around 400 operations per year including knee surgery (key hole surgery for torn cartilages), knee replacement, revision knee replacements, uni-compartmental knee replacement and conditions relating to a broken knee. Professor Jeys also specialises in the treatment of bone tumours and soft tissue tumours.

Professor Jeys has published over 100 scientific papers in the world’s most important orthopaedic Journals and has written three chapters in text books about surgery. He regularly lectures around the world on joint replacement and tumour surgery and is also a reviewer for leading Orthopaedic Journals, helping to decide whether research is robust enough to be published. Professor Jeys sits on several national committees including the National Cancer Research Institute and the National Cancer Intelligence Network.

Mr Morris

Guy Morris is an orthopaedic surgeon who specialises in the treatment of bone and soft tissue cancer (sarcoma), he is also an arthroplasty surgeon performing both primary and revision hip and knee replacements.

He completed an undergraduate degree in Sports Rehabilitation and Injury Prevention before graduating in Medicine from the University of Leicester in 2007. He undertook his higher surgical training in the West Midlands on the Birmingham Orthopaedic Training Program and obtained his Fellowship of the Royal College of Surgeons of England in Trauma and Orthopaedics in 2017. He then gained further experience in the specialist field of oncology and arthroplasty during his fellowship in in Sydney under Professor Paul Stalley at the Royal Prince Alfred Hospital; the largest sarcoma unit In Australia.

He has authored a number of papers in international journals and is himself a reviewer of scientific papers and textbooks. An honorary clinical lecturer at the Birmingham university, he has maintained an active interest in teaching and has lectured on FRCS revision courses, been an examiner for mock FRCS examinations and regularly contributes on the registrar teaching program.

Mr Parry

Michael Parry is a consultant orthopaedic surgeon at the Royal Orthopaedic Hospital specializing in orthopaedic oncology and primary and revision lower limb arthroplasty.

Michael undertook his undergraduate medical training at the University of Bristol qualifying in 2001. He continued his training in Oxford and the South East before returning to Bristol to complete his higher surgical training. He completed his Doctorate in Medicine in 2012 and was previously appointed as an NIHR clinical lecturer in orthopaedic surgery at the University of Bristol. He has completed fellowship training in lower limb arthroplasty in Vancouver and orthopaedic oncology here in Birmingham. Michael began working at the ROH in 2014 and is an Honorary Senior Lecturer at the University of Aston.

Michael’s specialist interests are in orthopaedic oncology and lower limb arthroplasty, with a particular interest in the management of infected joint replacements. Michael has published extensively in these fields and has continued to develop his research interests in both oncology and revision lower limb arthroplasty. He regularly presents at national and international conferences on behalf of the ROH and is a reviewer for a number of renowned orthopaedic journals.

Bio to follow

Mr Stevenson

Jonathan Stevenson is a specialist in oncology & arthroplasty at the Royal Orthopaedic Hospital NHS Trust.

He qualified at the University of Birmingham in 2005. He gained his specialist training at the Robert Jones & Agnes Hunt Orthopaedic Hospital, Oswestry and began working at the Royal Orthopaedic Hospital NHS Trust in 2015. He is a Senior Honorary Clinical Lecturer in Orthopaedics at Aston University.

He has been awarded multiple national research prizes in orthopaedic oncology from national bodies including the British Orthopaedic Association, British Orthopaedic Oncology Society Royal Society of Medicine. He was elected to the National Cancer Research Institute (NCRI) sarcoma clinical studies group in 2015.

He was awarded the British Orthopaedic Association International travelling fellowship award in 2014, visiting the Tata Memorial hospital in Mumbai and the British Orthopaedic Oncology Society European travelling fellowship award in 2015.

He has international scientific presentation experience since 2010 and has presented research at all major national and international orthopaedic oncology scientific meetings since 2014. He is a reviewer for the European Journal of Surgical Oncology. He regularly examines and lectures on FRCS (Tr & Orth) courses in clinical examination, viva examination and basic science.


Mr Tillman

Mr Tillman is a Consultant Orthopaedic Surgeon at the Royal Orthopaedic Hospital NHS Trust. He gained his specialist training in Manchester, Wrightington, Boston USA and the Mayo Clinic USA.

Mr Tillman specialises in primary and revision hip and knee replacement and hip resurfacing. He is a specialist in bone tumour surgery, and is a former president of the British Orthopaedic Oncology Society. Mr Tillman is an examiner for the Royal College of Surgeons in the Orthopaedic Fellowship.

Mr Kurisunkal

Mr Kurisunkal

Mr Vineet Kurisunkal is an orthopaedic oncologist who specialises in the treatment of benign & malignant bone and soft tissue tumours (sarcoma) and metastatic bone disease.

He completed his undergraduate and postgraduate orthopaedic training in India. He undertook his specialist fellowship training in orthopaedic oncology under Professor Ajay Puri and Professor Ashish Gulia at the prestigious Tata Memorial Centre, Mumbai, India, with one of the largest sarcoma centres in the world. He underwent further specialist training in navigation assisted pelvis and sacral sarcoma surgeries at the Royal Orthopaedic Hospital, Birmingham, certified by the Royal College of Surgeons, England.

He has authored a number of papers in the world’s most important orthopaedic journals and has written book chapters on sarcomas in various textbooks. He continues to develop his research interest in orthopaedic oncology which he presents at national and international conferences.


Scott Evans

Mr Evans qualified in 2004 and began basic surgical training in the North West of England. He undertook higher surgical training in the West Midlands on the Birmingham rotation, obtaining the FRCS (Tr&Orth) in 2015.  He is an Honorary Lecturer at The University of Birmingham.

He has been awarded multiple regional, national and international research prizes.

Mr Evans has published widely on various orthopaedic subjects and has presented work around the world.

He regularly examines and lectures on FRCS (Tr & Orth) courses in clinical examination, viva examination and basic science. He is an educational supervisor for undergraduates studying medicine. Mr Evans has completed fellowships at the world renowned orthopaedic oncology units in Birmingham and Oxford. Mr Evans’ main areas of clinical interest are orthopaedic oncology and arthroplasty.

Miss Foong 2024

Deborah Foong

Details coming soon.


Karthikeyan Srinivasan

Details coming soon.



Dr Christine Azzopardi

Dr Christine Azzopardi is a specialist consultant musculoskeletal radiologist whose NHS base is the Royal Orthopaedic Hospital, Birmingham. She qualified from the University of Malta and completed her postgraduate training in Mater Dei Hospital, Malta. Having obtained the MRCP in 2013 and the FRCR in 2015 Dr. Azzopardi then completed two fellowships in musculoskeletal and sarcoma radiology at the Royal Orthopaedic Hospital and The Nuffield Orthopaedic Centre in Oxford. 

Dr Azzopardi remained as a consultant musculoskeletal radiologist at The Nuffield Orthopaedic Centre, until August 2019 before joining the sarcoma and radiology team at the Royal Orthopaedic Hospital in September 2019.  She maintains a strong interest in sarcoma imaging and musculoskeletal intervention. She has co-authored multiple publications and has a keen interest in teaching.


Dr Botchu

Dr Botchu completed his MBBS and Masters in Orthopaedics from KMC, Kurnool, India. Subsequently he did basic surgical training in the UK. He did his radiology training at Norfolk and Norwich University Hospital, Norwich and University Hospitals of Leicester, Leicester. 

Following this he completed subspecialty training in Musculoskeletal Radiology at Nuffield Orthopaedic Centre, Oxford, Royal Orthopaedic Hospital, Birmingham and Cabinet d’Imagerie Médicale, Geneva. He was a Consultant Musculoskeletal Radiologist at Kettering General Hospital until 2014. 

Since then he has been a Consultant Musculoskeletal Radiologist at The Royal Orthopaedic Hospital. He is a member of ISS, ESSR, BSSR, MSS. He has published over 100 papers in peer reviewed journals and written over 8 chapters. He is the advisory editor for Clinical Radiology Journal and member of ESSR tumour sub-committee. 

He created the mskradiology4u app and website along with his colleagues at the Royal Orthopaedic Hospital. His main interests are diagnostic and interventional musculoskeletal radiology including bone and soft tissue tumour, spinal and sports imaging.


Dr Mark Davies

Dr Davies has been a consultant radiologist at the Royal Orthopaedic Hospital since 1984. He is a founding member and former Secretary of the British Society of Skeletal Radiology. He is also a founding member, First Secretary and former President of the European Society of Skeletal Radiology and the former secretary and president of the International Skeletal Society. 

Dr Davies has been a Part 2B FRCR Examiner for Royal College of Radiologists and an external examiner for the Hong Kong and Singapore College of Radiologists. He has co-edited 9 textbooks on musculoskeletal radiology and has written over 200 publications and more than 50 book chapters. 

He has formerly been an editorial board member of 5 imaging journals and is a co-developer of the MSK Radiology 4U App and website, and has delivered 5 eponymous lectures. He is and Honorary Member of the Hungarian Radiological Society and the European Society of Skeletal Radiology.


Dr Steve James

Dr Steven James is a Consultant Musculoskeletal Radiologist and Honorary Reader at the University of Birmingham, UK. He initially undertook his Radiology training at University Hospitals Nottingham before completing a fellowship at the Royal National Orthopaedic Hospital, London in Musculoskeletal and Spinal imaging with an emphasis on interventional techniques. He was appointed in 2006 to a substantive post at the Royal Orthopaedic Hospital NHS Foundation Trust, Birmingham.

Dr James has helped develop the diagnostic and interventional management of primary bone tumours during his time in Birmingham. Dr James has a strong research interest and has over 100 publications in peer reviewed scientific journals on Orthopaedic, Spinal and Sports injury related topics. He has edited 2 textbooks and written numerous book chapters. He regularly lectures at national and international meetings on musculoskeletal, spinal and oncology related topics.


Dr Patel

Dr Patel has been a musculoskeletal and interventional radiologist at the Royal Orthopaedic Hospital since 2017. Prior to this, he was a consultant musculoskeletal radiologist at the Royal Devon and Exeter Hospital, UK, for 2 years. 

He undertook his radiology training in the Peninsula Deanery, obtaining FRCR in 2012. He undertook a post-CCT fellowship in Musculoskeletal and Interventional Radiology at the Royal Orthopaedic Hospital, Birmingham, UK. He has also spent time at Imaging @Olympic Park (IOP) in Melbourne Australia which is a specialist centre for sports injuries and its innovative treatment of musculoskeletal conditions. Clinically, his interests include bone and soft tissue tumour imaging and all types of spinal and musculoskeletal intervention. 

He is currently setting up a new cryotherapy service for the treatment of certain types of bone and soft tissue tumours. He has over 20 publications and a number of book chapters.  

Clinical nurse specialists


Anita Killingworth

Anita is a Macmillan Oncology Nurse Consultant and Lead Cancer Nurse for the Trust. She is involved in every step of the patient’s pathway from triaging new referrals, making contact with patients and families pre-diagnosis and giving support throughout the treatment pathway and follow-up. 

She runs the nurse led two week wait clinics for new patients and follow up clinics for patients with sarcoma alongside the Advanced Nurse Practitioners in the team and she co-ordinates the care and running of a specialist clinic for patients with giant cell tumours of bone. 

She leads and supports the specialist nursing team in setting up new nurse-led clinics and developing clinical practice in new directions to benefit patient care. As the Lead Cancer Nurse, her role also encompasses a strategic aspect which is a vital opportunity to take practice forward and to ensure the patient voice is heard at every level of the organisation and nationally and that the clinical team is sufficiently supported.


Andrea Slade

Andrea qualified as a registered nurse from the University of Birmingham in 1995, she started work for the bone tumour service as a ward based staff nurse and has worked here since. In 2003 she studied for her Masters degree in Advanced Clinical Practice and commenced her role as a Macmillan Advanced Nurse Practitioner in 2006.

The role involves the triage of new referrals in to the service, support of the diagnostic MDT and initiating contact with the patient and/or relative. She meets the patient at their first consultation, provides information and support throughout their cancer journey. She works closely with the pelvic surgery team and is keyworker for the adult pelvic surgery patients. She also runs nurse led clinics for GP urgent referrals and sarcoma follow up patients.

Debra Dunne

Debra qualified as a registered nurse in Coventry and Warwickshire school of nursing and Midwifery 1991. Initially working in Trauma and Orthopaedics in Coventry Debra then got a job on the Adult Oncology ward at the Royal Orthopaedic Hospital in 1997 initially as a staff nurse, completing her BSc nursing degree with specialist practitioner in adult oncology qualification. 

Debra then progressed to the role of the Ward Manager on the adult oncology ward. In 2003 Debra returned to Coventry to study for her Masters degree in Advanced Clinical Practice at Birmingham University. Debra took up the role of Advanced Nurse Practitioner in Trauma and Orthopaedics until she returned to the Royal Orthopaedic Hospital in 2021 as a MacMillan Advanced Nurse Practitioner.

Her role involves supporting patients and their families / carers along their patient journey from pre-diagnosis, hospital admission and ongoing clinical review. Debra along with Andrea run the two week wait sarcoma clinics for new and follow up appointments.


Louise Cook

I support children, young people and their families before and throughout the diagnosis process. My role is to provide information and give continued support through the surgical pathway and follow up. Prior to this I worked as a Teenage Cancer Trust Clinical Nurse Specialist and before this I worked as a staff Nurse on a Teenage Cancer Trust Unit at Birmingham Children’s Hospital.


Claire Hinwood

Claire is the Transition to adult services Clinical Nurse Specialist. Her role is to provide specialist care, support and advice to all young adult patients aged 16 -18 and their families, within the hospital, who are being treated in adult services.

She also supports Orthopaedic patients from the age of 12 years, to help prepare them for the transition into adult services within this Trust and at Birmingham Women’s and Children’s Hospital.

Picture by www.edwardmoss.co.uk
All rights reserved
Royal Orthopaedic Hospital Birmingham

Nerys Davis

Bio to follow


Nicola Betteridge


Genevieve Davies

Bio coming soon 

Emily Harris

Bio coming soon 

University Hospitals Birmingham



Mr Max Almond

Mr Almond completed his undergraduate training at Birmingham Medical School in 2004. In 2010 he was awarded a Royal College of Surgeons Research Fellowship following which he obtained a Doctorate of Medicine, awarded with distinction, for his work on early spectroscopic diagnosis of oesophageal cancer.

Mr Almond completed subspecialty training in resectional oesophagogastric and hepatobiliary surgery in 2016, and then undertook a Royal College of Surgeons Retroperitoneal Sarcoma Fellowship at UHB. This was followed by two travelling fellowships to the Sarcoma Units in Milan and the Royal Marsden Hospital.

Mr Almond’s specialist interests include abdominal, pelvic and retroperitoneal sarcoma, surgery for gastrointestinal neuroendocrine tumours, minimally invasive (laparoscopic) cancer surgery, benign upper gastrointestinal surgery and advanced therapeutic endoscopy including ERCP.

He has published more than sixty research papers and book chapters relating to Sarcoma, Surgical Oncology and General Surgery. He is currently supervising a doctoral student working on objective spectroscopic diagnosis in soft tissue sarcoma. He is also leading several research studies in collaboration with the Sarcoma Unit in Milan through his membership of the Trans-Atlantic Retroperitoneal Sarcoma Working Group.


Mr Anant Desai

Mr Anant Desai completed undergraduate education at Queens’ College Cambridge and the Royal Free Hospital, London.

Following this he gained an MD investigating angiogenesis in oesophageal cancer at the University of Birmingham before completing Fellowships in Paris and Milan. He was appointed as Consultant Surgeon to the Midlands Abdominal and Retroperitoneal Sarcoma Unit in 2011.

Mr Desai undertakes all aspects of abdominal sarcoma surgery as well as complex surgical oncology and surgery for advanced pelvic malignancy.

Research interests include whole genomic sequencing in sarcoma and pre-operative psychological intervention in patients undergoing major surgery. Publications range from International Consensus statements for the treatment of sarcoma to multi-centre studies of rare tumours.

Mr Desai is a member of the Sarcoma UK research advisory committee, is an editor of the European Journal of Surgical Oncology, is co-chair of the West Midlands Sarcoma Advisory Group and leads the regional soft tissue sarcoma multi-disciplinary team.


Mr Sam Ford

Mr Ford studied undergraduate medicine at the University of Birmingham and graduated with Honours in 2001.

He was the Cancer Research UK Clinical Research Fellow for three years and was awarded a PhD in 2012 for the role of iron in cancer development. He gained fellowship to the Royal College of Surgeons in 2013 and completed his surgical training in 2014 after training in general and upper GI surgery throughout the South West. Mr Ford then undertook clinical fellowships in sarcoma surgery in Birmingham and Milan, with appointment to Consultant Sarcoma Surgeon in 2015.

His specialist interests include complex surgical oncology, especially abdominal, pelvic and retroperitoneal sarcoma.

Mr Ford has published papers on all aspects of upper GI surgery, molecular oncology and soft tissue sarcoma. He has contributed to International Consensus statements on the management of sarcoma and is a member of the Trans-Atlantic Retroperitoneal Sarcoma Working Group.



Dr Jenny Sherriff

Since obtaining her medical degree, MBChB with honours, from the University of Birmingham (2003), Dr Sherriff completed her general medical, MRCP (2007) and subsequent clinical oncology training, FRCR (2011), in the West Midlands.

She began as an oncology consultant in 2013 with specialist interests in sarcoma, breast cancer and advanced radiotherapy techniques, including stereotactic ablative body radiotherapy (SABR), for which she is the clinical lead at UHB.

Dr Sherriff has spent time in Toronto, through the RCR Kay fellowship, developing a specialist interest in SABR for spine metastases. She has a keen interest in research and is currently principal investigator for a number of national and international sarcoma clinical trials at UHB.


Dr Mariam Jafri

Dr Jafri qualified from the University of Birmingham and completed her postgraduate training in internal medicine in Birmingham obtaining MRCP in 2006.

She received her postgraduate oncology training in Oxford and Birmingham, obtaining her MRCP (Medical Oncology) in 2012. She was awarded an MRC Clinical Training fellowship in cancer genetics under the supervision of Professor  Eamonn Maher, obtaining a PhD from  the University of Birmingham in 2016.

Dr Jafri was appointed as a consultant in medical oncology in July 2016. Her clinical interests are sarcoma, germ cell tumours and breast cancer.

She is the lead clinician for teenagers and young adults and represents the Midlands on the NHS Clinical Reference Group for Children and Young Adults with Cancer. Her interests include medical oncology training and clinical trials.


Dr David Peake

Biography pending.

Clinical nurse specialists


Natalie Harvey

Natalie qualified as a registered general nurse from the University of Central England, Birmingham in 2001, and in 2005 she received a further BSc Hons with Specialist Practitioner Award.

Her early career was spent working within acute oncology wards at UHB. In 2007, while working as a sister in this setting, she also started a role as Professional Development Sister for Oncology/Haematology. This role helped develop her teaching knowledge which was enhanced in 2009 when she obtained a City and Guilds Diploma in Teaching in the lifelong learning sector.

In 2010 she undertook an MSc in Clinical Oncology (the palliative care and the cancer patient module) to broaden her knowledge and skills for her patients.

Natalie was then appointed as a Macmillan Sarcoma Clinical Nurse Specialist in October 2010 to set up the nursing side of MARSU.

She is a member of the British Sarcoma Group, and has lectured on their nurse educational days as well as developing protocols to enhance patient services.

Birmingham Women’s and Children’s Hospital



Dr David Hobin

Dr Hobin has been a consultant at Birmingham Children’s Hospital since 2003 and looks after children and teenagers with a wide variety of solid tumours outside of the brain or spinal cord and is part of the ‘Solid Tumour Multidisciplinary Team (MDT)’. Dr Hobin cares for patients through both inpatient and outpatient services. Dr Hobin’s principal areas of interest are in Teenage and Young Adult (TYA) Oncology, Sarcoma, and Lymphoma. He is currently the Chair of the national professional group for TYA oncology – TYAC. Dr Hobin is also a member of the UK Expert advisory group for autografts in children and represents the Children’s Cancer and Leukaemia group (CCLG) and TYAC on the UK chemotherapy Board.

Dr Hobin is the Principal Investigator for a number of Phase III trials currently open in the department including trials for the treatment of Neuroblastoma, Sarcoma and Hodgkin’s Lymphoma.


Dr Francis Mussai

Dr Mussai trained at Oxford University and has worked at some of the top cancer facilities in the world including Johns Hopkins Hospital in Baltimore, USA and the National Cancer Institute in Washington DC, USA. 

Dr Mussai looks after children diagnosed with solid cancers and can be seen on the ward and in the outpatient clinic. He leads the International Fellowship Programme in the department which has now trained doctors from around the world. He is involved in early phase clinical trials of novel therapeutic drugs and sits on the Innovative Therapies for Children with Cancer (ITCC) Clinical Trials Committee, as well as a number of national committees involved in identifying new drugs for children with cancer. 

Dr Mussai investigates how solid cancers and leukaemias interact with the immune system and has a research laboratory at the University of Birmingham. By improving our understanding of how cancers escape from immune attack he believes new therapies can be developed to improve the outcome for our patients. He has published a number of papers in this field. The laboratory’s research has led to a number of international clinical trials of new drugs and immunotherapies.